MedPath

Efficacy and Safety of Gynostemma Pentaphyllum(Dungkulcha) Extract on Alleviation of Chronic Stress-induced Strain

Not Applicable
Completed
Conditions
Chronic Stress-Induced Strain
Interventions
Dietary Supplement: Placebo
Dietary Supplement: Gynostemma Pentaphyllum(Dungkulcha) Extract(400mg/day)
Registration Number
NCT03277833
Lead Sponsor
Chonbuk National University Hospital
Brief Summary

The investigators performed a 8-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Gynostemma Pentaphyllum(Dungkulcha) on alleviation of chronic stress-induced strain. The investigators measured decrement of body fat parameters, State\&Trait version of STAI, Beck Anxiety Inventory(BAI), Hamilton Anxiety Inventory(HAM-A), and monitored their blood pressure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria

• Age 20-65 years with chronic stress( S-STAI score 40~60)

Exclusion Criteria
  • excessive physically chronic fatigue
  • Subjects taking antidepressants, anxiolytics, hypnotics within the last 2 months prior to the study
  • Cardiovascular disease
  • Allergic or hypersensitive to any of the ingredients in the test products
  • History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
  • Participation in any other clinical trials within past 2 months
  • Renal disease
  • Abnormal hepatic function
  • Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
  • History of alcohol or substance abuse
  • Pregnancy or lacting women etc.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboPlacebo
Gynostemma Pentaphyllum(Dungkulcha) ExtractGynostemma Pentaphyllum(Dungkulcha) Extract(400mg/day)Gynostemma Pentaphyllum(Dungkulcha) Extract (400mg/d)
Primary Outcome Measures
NameTimeMethod
Change in score of State&Trait version of STAIBaseline and 8 weeks

Score of State\&Trait version of STAI was measured in study screening and visit 3(8 week).

Secondary Outcome Measures
NameTimeMethod
Change of Blood Norepinephrine LevelBaseline and 8 week

Blood norepinephrine level was measured in study visit 1(0 week) and visit 3(8 week).

Change of Blood Cortisol LevelBaseline and 8 week

Blood cortisol level was measured in study visit 1(0 week) and visit 3(8 week).

Change in score of Beck Anxiety InventoryBaseline and 8 week

Score of Beck Anxiety Inventory was measured in study visit 1(0 week) and visit 3(8 week).

© Copyright 2025. All Rights Reserved by MedPath